Advocacy intelligence hub — real-time data for patient organizations
Universidad Nacional Andres Bello — NA
Hanny Al-Samkari, MD — PHASE2
Rebiscan, Inc.
Refluden: FDA approved
For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Refluden
Hoechst Marion Roussel
Refluden
(Lepirudin)Orphan drugHoechst Marion Roussel
Hanny Al-Samkari, MD
Massachusetts General Hospital
📍 Miami, Florida
Robert L Levine
The University of Texas, Houston
View all Classic heparin-induced thrombocytopenia specialists →